Cabot Corp Files Definitive Proxy Statement (DEF 14A)

Ticker: CBT · Form: DEF 14A · Filed: Jan 26, 2024 · CIK: 16040

Complexity: moderate

Sentiment: neutral

Topics: DEF 14A, Proxy Statement, Cabot Corp, Corporate Governance, Shareholder Meeting

TL;DR

<b>Cabot Corp has filed its Definitive Proxy Statement (DEF 14A) for the period ending March 7, 2024.</b>

AI Summary

CABOT CORP (CBT) filed a Proxy Statement (DEF 14A) with the SEC on January 26, 2024. Cabot Corp filed a Definitive Proxy Statement (DEF 14A) on January 26, 2024. The filing covers the period ending March 7, 2024. The company's fiscal year ends on September 30. Cabot Corp's principal executive offices are located at Two Seaport Lane, Suite 1400, Boston, MA. The company was formerly known as Cabot Godfrey L Inc.

Why It Matters

For investors and stakeholders tracking CABOT CORP, this filing contains several important signals. This DEF 14A filing is a standard disclosure for publicly traded companies, providing shareholders with information regarding annual meetings, director nominations, executive compensation, and other corporate governance matters. Shareholders should review this document to understand key proposals, director qualifications, and compensation structures before the annual meeting.

Risk Assessment

Risk Level: low — CABOT CORP shows low risk based on this filing. The filing is a routine DEF 14A, which typically contains standard disclosures and does not present new material risks.

Analyst Insight

Review the proxy statement for details on executive compensation, director nominees, and any shareholder proposals to inform voting decisions.

Key Numbers

Key Players & Entities

FAQ

When did CABOT CORP file this DEF 14A?

CABOT CORP filed this Proxy Statement (DEF 14A) with the SEC on January 26, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by CABOT CORP (CBT).

Where can I read the original DEF 14A filing from CABOT CORP?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by CABOT CORP.

What are the key takeaways from CABOT CORP's DEF 14A?

CABOT CORP filed this DEF 14A on January 26, 2024. Key takeaways: Cabot Corp filed a Definitive Proxy Statement (DEF 14A) on January 26, 2024.. The filing covers the period ending March 7, 2024.. The company's fiscal year ends on September 30..

Is CABOT CORP a risky investment based on this filing?

Based on this DEF 14A, CABOT CORP presents a relatively low-risk profile. The filing is a routine DEF 14A, which typically contains standard disclosures and does not present new material risks.

What should investors do after reading CABOT CORP's DEF 14A?

Review the proxy statement for details on executive compensation, director nominees, and any shareholder proposals to inform voting decisions. The overall sentiment from this filing is neutral.

How does CABOT CORP compare to its industry peers?

Cabot Corp operates in the specialty chemicals sector, focusing on performance materials. This DEF 14A filing is a routine disclosure for a publicly traded company in this industry.

Are there regulatory concerns for CABOT CORP?

The DEF 14A filing is mandated by the Securities Exchange Act of 1934, requiring public companies to provide detailed information to shareholders regarding corporate governance and voting matters.

Industry Context

Cabot Corp operates in the specialty chemicals sector, focusing on performance materials. This DEF 14A filing is a routine disclosure for a publicly traded company in this industry.

Regulatory Implications

The DEF 14A filing is mandated by the Securities Exchange Act of 1934, requiring public companies to provide detailed information to shareholders regarding corporate governance and voting matters.

What Investors Should Do

  1. Review executive compensation details and any proposed changes.
  2. Examine the backgrounds and qualifications of director nominees.
  3. Understand any shareholder proposals and the company's recommendation.

Year-Over-Year Comparison

This filing is a DEF 14A, a routine disclosure, and does not represent a change in reporting frequency or type compared to previous filings.

Filing Stats: 4,757 words · 19 min read · ~16 pages · Grade level 12.9 · Accepted 2024-01-26 13:41:15

Filing Documents

Executive Compensation

Executive Compensation 33 Compensation Committee Report 33 Compensation Discussion and Analysis 33 Summary Compensation Table 53 Grant of Plan-Based Awards Table 55 Outstanding Equity Awards at Fiscal Year-End Table 57 Option Exercises and Stock Vested Table 58 Pension Benefits 58 Deferred Compensation 59 Potential Payments Upon Termination or Change in Control 61 CEO Pay Ratio 66 Pay versus Performance 67 Proposal 2 — Advisory Approval of Executive Compensation 71 Proposal 3 — Approval of the Cabot Corporation 2024 Non-Employee Director Plan 72 Audit Committee Matters 75 Audit Committee Report 75 Audit Fees 76 Audit Committee Pre-Approval Policy 76 2024 PROXY STATEMENT Table of Contents (continued) Proposal 4 — Ratification of Appointment of Independent Registered Public Accounting Firm 77 Other Information 78 Equity Compensation Plan Information 78 Future Stockholder Proposals and Director Nominations 78 Available Information 79 Solicitation of Proxies 79 Miscellaneous 79 Appendix A — Non-GAAP Measures A-1 Appendix B — Cabot Corporation 2024 Non-Employee Director Plan B-1 2024 PROXY STATEMENT About the Annual Meeting Cabot Corporation Two Seaport Lane, Suite 1400 Boston, Massachusetts 02210-2019 Proxy Statement References to "the Company", "Cabot", "we", "us", and "our" in this proxy statement mean Cabot Corporation. About the Annual Meeting Who is soliciting my vote? The Board of Directors of Cabot Corporation is soliciting your vote at the 2024 Annual Meeting of Stockholders (the "2024 Annual Meeting" or the "meeting"). What am I voting on? You are voting on: Proposal 1: Election of Cynthia A. Arnold, Douglas G. Del Grosso, and Christine Y. Yan to the class of directors whose term expires in 2027 ( see page 19 ); Proposal 2: Advisory approval of our executive compensation (commonly referred to as "say-on-pay") ( see page 71 );

Forward-Looking Statements

Forward-Looking Statements This proxy statement may contain "forward-looking statements" under the federal securities laws. These forward-looking statements include information concerning our possible or assumed future business strategies, potential growth opportunities, potential operating performance improvements, and expectations related to governance and management. Generally, the words "believe," "expect," "plan," "intend," "anticipate," "estimate," "predict," "potential," "continue," "may," "should" or the negative of these terms or similar expressions that do not relate to historical facts are intended to identify forward-looking statements. Forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, potentially inaccurate assumptions, and other factors, some of which are beyond our control or difficult to predict. If known or unknown risks materialize, our actual results could differ materially from past results and from those expressed in the forward-looking statements. Investors are therefore cautioned not to place undue reliance on forward-looking statements. Important factors that could cause our results to differ materially from those expressed or implied in the forward-looking statements include, but are not limited to, industry capacity utilization and competition from other specialty chemical companies; safety, health and environmental requirements and related constraints imposed on our business; regulatory and financial risks related to climate change developments; volatility in the price and availability of energy and raw materials, including with respect to the Russian invasion of Ukraine; a significant adverse change in a customer relationship or the failure of a customer to perform its obligations under agreements with us; failure to achieve growth expectations from new products, applications and technology developments; failure to realize benefits from acquisitions, alliances, or joint ventur

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing